Cargando…
Characterization of Stenotrophomonas maltophilia phage AXL1 as a member of the genus Pamexvirus encoding resistance to trimethoprim–sulfamethoxazole
Stenotrophomonas maltophilia is a ubiquitous environmental bacterium capable of causing disease in humans. Antibiotics are largely ineffective against this pathogen due to numerous chromosomally encoded antibiotic resistance mechanisms. An alternative treatment option is phage therapy, the use of ba...
Autores principales: | McCutcheon, Jaclyn G., Lin, Andrea, Dennis, Jonathan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206674/ https://www.ncbi.nlm.nih.gov/pubmed/35717537 http://dx.doi.org/10.1038/s41598-022-14025-z |
Ejemplares similares
-
Isolation and Characterization of the Novel Bacteriophage AXL3 against Stenotrophomonas maltophilia
por: McCutcheon, Jaclyn G., et al.
Publicado: (2020) -
Stenotrophomonas maltophilia resistant to trimethoprim – sulfamethoxazole: an increasing problem
por: Al-Jasser, Asma Marzouq
Publicado: (2006) -
The Potential of Phage Therapy against the Emerging Opportunistic Pathogen Stenotrophomonas maltophilia
por: McCutcheon, Jaclyn G., et al.
Publicado: (2021) -
Osteomyelitis due to Stenotrophomonas maltophilia treated with trimethoprim-sulfamethoxazole monotherapy
por: Osakwe, Nonso
Publicado: (2023) -
Novel Stenotrophomonas maltophilia temperate phage DLP4 is capable of lysogenic conversion
por: Peters, Danielle L., et al.
Publicado: (2019)